Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer

by Che-Kai Tsao, Sonia Seng, William K. Oh, Matthew D. Galsky
Published 2011-01-01

Pan-cancer proteogenomic investigations identify post-transcriptional kinase targets

by Abdulkadir Elmas, Serena Tharakan, Suraj Jaladanki, Matthew D. Galsky, Tao Liu, Kuan-lin Huang
Published 2021-09-01

Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications

by Che-Kai Tsao, Bobby Liaw, Catherine He, Matthew D. Galsky, John Sfakianos, William K. Oh
Published 2017-04-01

Concurrent diabetes mellitus may negatively influence clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer

by Jeffrey eShevach, Emily Jane Gallagher, Teena eKochukoshy, Victoria eGresia, Manpreet eBrar, Matthew D Galsky, William K Oh
Published 2015-06-01

A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles

by Li Wang, Robert P. Sebra, John P. Sfakianos, Kimaada Allette, Wenhui Wang, Seungyeul Yoo, Nina Bhardwaj, Eric E. Schadt, Xin Yao, Matthew D. Galsky, Jun Zhu
Published 2020-02-01

Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers

by John P. Sfakianos, Jorge Daza, Yang Hu, Harry Anastos, Geoffrey Bryant, Rohan Bareja, Ketan K. Badani, Matthew D. Galsky, Olivier Elemento, Bishoy M. Faltas, David J. Mulholland
Published 2020-05-01

A Common Pituitary Autoantibody in Two Patients with Immune Checkpoint Inhibitor-Mediated Hypophysitis: ZCCHC8

by Amanda Leiter, MD, MSCR, Sacha Gnjatic, PhD, Mary Fowkes, MD, PhD, Seunghee Kim-Schulze, PhD, Ilaria Laface, PhD, Matthew D. Galsky, MD, Emily J. Gallagher, MD, PhD
Published 2020-07-01

The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic

by Sudeh Izadmehr, Sudeh Izadmehr, Sudeh Izadmehr, Dara J. Lundon, Nihal Mohamed, Nihal Mohamed, Andrew Katims, Vaibhav Patel, Vaibhav Patel, Benjamin Eilender, Reza Mehrazin, Reza Mehrazin, Ketan K. Badani, Ketan K. Badani, John P. Sfakianos, John P. Sfakianos, Che-Kai Tsao, Che-Kai Tsao, Peter Wiklund, William K. Oh, William K. Oh, Carlos Cordon-Cardo, Carlos Cordon-Cardo, Ashutosh K. Tewari, Ashutosh K. Tewari, Matthew D. Galsky, Matthew D. Galsky, Natasha Kyprianou, Natasha Kyprianou, Natasha Kyprianou, Natasha Kyprianou
Published 2021-09-01

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

by Gary D Steinberg, Neal Shore, Petros Grivas, Matthew D Galsky, Elizabeth R Plimack, Shilpa Gupta, Arjun V Balar, Peter C Black, Matthew T Campbell, Gail S Dykstra, Christoper J Hoimes, Lidia P Lopez, Joshua J Meeks, Jonathan E Rosenberg, Ashish M Kamat
Published 2021-07-01

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

by Ashish M. Kamat, Joaquim Bellmunt, Matthew D. Galsky, Badrinath R. Konety, Donald L. Lamm, David Langham, Cheryl T. Lee, Matthew I. Milowsky, Michael A. O’Donnell, Peter H. O’Donnell, Daniel P. Petrylak, Padmanee Sharma, Eila C. Skinner, Guru Sonpavde, John A. Taylor, Prasanth Abraham, Jonathan E. Rosenberg
Published 2017-09-01

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

by Ashish M. Kamat, Joaquim Bellmunt, Matthew D. Galsky, Badrinath R. Konety, Donald L. Lamm, David Langham, Cheryl T. Lee, Matthew I. Milowsky, Michael A. O’Donnell, Peter H. O’Donnell, Daniel P. Petrylak, Padmanee Sharma, Eila C. Skinner, Guru Sonpavde, John A. Taylor, Prasanth Abraham, Jonathan E. Rosenberg
Published 2017-08-01

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

by Li Wang, Abdel Saci, Peter M. Szabo, Scott D. Chasalow, Mireia Castillo-Martin, Josep Domingo-Domenech, Arlene Siefker-Radtke, Padmanee Sharma, John P. Sfakianos, Yixuan Gong, Ana Dominguez-Andres, William K. Oh, David Mulholland, Alex Azrilevich, Liangyuan Hu, Carlos Cordon-Cardo, Hélène Salmon, Nina Bhardwaj, Jun Zhu, Matthew D. Galsky
Published 2018-08-01

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database

by Gabriella Del Bene, Fabio Calabrò, Diana Giannarelli, Elizabeth R. Plimack, Lauren C. Harshman, Evan Y. Yu, Simon J. Crabb, Sumanta Kumar Pal, Ajjai S. Alva, Thomas Powles, Ugo De Giorgi, Neeraj Agarwal, Aristotelis Bamias, Sylvain Ladoire, Andrea Necchi, Ulka N. Vaishampayan, Günter Niegisch, Joaquim Bellmunt, Jack Baniel, Matthew D. Galsky, Cora N. Sternberg
Published 2018-11-01

The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies.

by Fallon K Noto, Jaya Sangodkar, Bisoye Towobola Adedeji, Sam Moody, Christopher B McClain, Ming Tong, Eric Ostertag, Jack Crawford, Xiaohua Gao, Lauren Hurst, Caitlin M O'Connor, Erika N Hanson, Sudeh Izadmehr, Rita Tohmé, Jyothsna Narla, Kristin LeSueur, Kajari Bhattacharya, Amit Rupani, Marwan K Tayeh, Jeffrey W Innis, Matthew D Galsky, B Mark Evers, Analisa DiFeo, Goutham Narla, Tseten Y Jamling
Published 2020-01-01